TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive States Join Suit Alleging Amgen Offered Illegal Kickback To Doctors For Aranesp November 6, 2009
TCL Archive An Unlucky Streak? Doctors Analyze Errors As Another Cancer Center Offers Apology June 30, 1995
TCL Archive NCAB May Make Its Recommendation On Comprehensive Center Issues At September Meeting August 5, 1988